Lung colonization and metastasis by disseminated b16 melanoma cells: H‐2 associated control at the level of the host and the tumor cell

We have studied the experimental metastasis of H‐2+ and H‐2− melanoma sublines in H‐2b/b and H‐2a/b hosts by enumerating pulmonary colonies 20–50 days after i.v. inoculation of tumor cells. In H‐2b/b hosts, the H‐2+ „B 16‐S”︁ cells gave rise to a moderate number of metastatic colonies (mean: 6.3 ± 6). The „BL 16‐L”︁ sublines that had lost the expression of MHC class I antigens, according to FACS‐analysis and quantitative absorption tests, gave no metastases under the same conditions. Pretreatment of the H‐2+ met+ B 16‐S with interferons (beta or alpha + beta) increased their H‐2 antigen expression and the number of metastatic colonies (mean: 25 ± 16). Interferon pretreatment of B16‐L cells partially restored their H‐2b expression and induced them to form a small number of metastatic colonies. The reduction in pulmonary colonization by the H‐2 negative B16‐L cells could be attributed to their rapid elimination by natural killer cells, already observed within 24 hr of inoculation of radiolabelled cells. H‐2− B16‐L cells were more susceptible than H‐2+ B16‐S cells to in vitro lysis by poly I:C‐treated splenocytes, and they acquired full metastatic abilities if the hosts were treated with anti‐asialo GM‐I serum. In H‐2a/b heterozygous hosts, the H‐2+ B16‐S cells also failed to metastasize. Reduced pulmonary colonization was evident by 24 hr after injection in comparison with H‐2b/b hosts, and could be reversed by anti‐asialo GM‐I treatment of the hosts. In vitro, H‐2a/b splenocytes were more cytotoxic to the B16 cells than syngeneic effectors. The results are discussed in relation to a recent hypothesis on a surveillance mechanism for elimination of cells on the basis of their lack (or insufficient expression) of host MHC genes.

[1]  V. Miller,et al.  Suppression of NK-mediated natural resistance by interferon treatment of murine lymphomas. , 1984, Journal of immunology.

[2]  S. Segal,et al.  Immuno‐selection In vivo of H‐2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence , 1984, International journal of cancer.

[3]  E. Gorelik,et al.  Role of nk cells in the antimetastatic effect of anticoagulant drugs , 1984, International journal of cancer.

[4]  P. Lollini,et al.  IMPAIRED H‐2 EXPRESSION IN B 16 MELANOMA VARIANTS , 1983, Journal of immunogenetics.

[5]  P. Beverley,et al.  Interferon, β-2-microglobulin and immunoselection in the pathway to malignancy A blinkered view from Nag's Head Yard. , 1983, Immunology today.

[6]  P. De Baetselier,et al.  Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells. , 1983, Journal of the National Cancer Institute.

[7]  S. Segal,et al.  MHC imbalance and metastatic spread in Lewis lung carcinoma clones , 1983, International journal of cancer.

[8]  S. Ferrone,et al.  Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. , 1983, Journal of immunology.

[9]  G. Klein,et al.  Thymus independence of hybrid resistance against a panel of T‐cell lymphomas of H‐2b origin , 1982, International journal of cancer.

[10]  R. Burton,et al.  Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. , 1981, Journal of immunology.

[11]  N. Tamaoki,et al.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. , 1981, Journal of immunology.

[12]  S. Segal,et al.  Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice. , 1981, Journal of the National Cancer Institute.

[13]  K. Ozato,et al.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. , 1981, Journal of immunology.

[14]  R. Welsh,et al.  Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells. , 1981, Journal of immunology.

[15]  S. Segal,et al.  Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties , 1980, Nature.

[16]  G. Carlson,et al.  H‐2 associated resistance to leukaemia transplantation: Natural killing in vivo , 1980, International journal of cancer.

[17]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[18]  C. Riccardi,et al.  Rapid in vivo assay of mouse natural killer cell activity. , 1979, Journal of the National Cancer Institute.

[19]  William E. Stewart,et al.  The Interferon System , 1979, Springer Vienna.

[20]  M. Edidin,et al.  Effect of the H-2 gene complex rates of fibroblast intercellular adhesion , 1978, The Journal of cell biology.

[21]  E. Clark,et al.  Resistance of H-2 heterozygous mice to parental tumors. II. Characterization of Hh-1 controlled hybrid resistance to syngeneic fibrosarcomas and the EL-4 lymphoma. , 1977, Journal of immunology.

[22]  I. Fidler,et al.  Relationship of host immune status to tumor cell arrest, distribution, and survival in experimental metastasis , 1977, Cancer.

[23]  I. Hilgert,et al.  Search for the physiological function of H‐2 gene products , 1977, European journal of immunology.

[24]  I. Gresser,et al.  Differential effects of interferon on the expression of H-2K, H-2D, and Ia antigens on mouse lymphocytes. , 1977, Journal of immunology.

[25]  G. Klein,et al.  Non‐T‐cell resistance against a mouse moloney lymphoma , 1976, International journal of cancer.

[26]  M. Bennett,et al.  PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTS , 1971, Journal of Experimental Medicine.

[27]  F. Burnet,et al.  “Self-recognition” in Colonial Marine Forms and Flowering Plants in relation to the Evolution of Immunity , 1971, Nature.

[28]  C. Mckhann,et al.  ANTIGENIC SPECIFICITIES ON MURINE SARCOMA CELLS , 1971, The Journal of experimental medicine.

[29]  K. Kärre ROLE OF TARGET HISTOCOMPATIBILITY ANTIGENS IN REGULATION OF NATURAL KILLER ACTIVITY: A REEVALUATION AND A HYPOTHESIS1 , 1985 .

[30]  P. Doherty,et al.  Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. , 1984, Advances in cancer research.

[31]  K. Kärre,et al.  THE BEIGE MODEL IN STUDIES OF NATURAL RESISTANCE TO SYNGENEIC, SEMISYNGENEIC, AND PRIMARY TUMORS , 1982 .